对比增强计算机断层扫描监测频率对I-III期结直肠癌患者生存结局的影响:一项倾向性评分匹配的回顾性队列研究
该回顾性队列研究纳入2012年1月至2020年1月在云南省肿瘤医院接受根治性切除的2180例I-III期结直肠癌患者,按随访中对比增强CT比例分为高频率组(>50%)和低频率组(≤50%),经1:4倾向性评分匹配后比较总生存和无病生存。中位随访78.78个月,两组总生存(HR 1.106,95%CI 0.696-1.757,P=0.671)和无病生存(HR 0.978,95%CI 0.666-1.438,P=0.911)均无显著差异,提示减少对比增强CT频率似乎未影响生存结局。
要点
- I-III期结直肠癌根治术后随访中,低频率对比增强CT组与高频率组总生存和无病生存均无显著差异。
- 倾向性评分匹配后高频率组432例、低频率组111例,基线特征均衡(所有标准化均数差<0.1)。
- 亚组分析未显示显著交互作用,多变量分析证实对比增强CT频率与结局无关。
核心结论
- 在本队列中,减少对比增强CT频率似乎未损害总生存或无病生存,支持在选定患者中潜在降级随访,但尚待前瞻性验证。
研究设计与样本
- 回顾性队列研究,纳入2012年1月至2020年1月在云南省肿瘤医院接受根治性切除的连续I-III期结直肠癌患者2180例,按随访扫描中对比增强CT比例>50%为高频率组、≤50%为低频率组,采用1:4最近邻倾向性评分匹配(卡钳值0.05),匹配变量包括年龄、性别、肿瘤分期、手术方式、辅助化疗、肿瘤位置和术前癌胚抗原水平。
诊断标准与关键数值
- 高频率组定义为随访扫描中>50%为对比增强CT,低频率组定义为≤50%;匹配后高频率组432例、低频率组111例;总生存HR 1.106(95%CI 0.696-1.757,P=0.671),无病生存HR 0.978(95%CI 0.666-1.438,P=0.911)。
临床应用与阅片要点
- 原文结论提示减少对比增强CT频率似乎未损害总生存或无病生存,支持在选定患者中潜在降级随访,但尚待前瞻性验证;作者未给出具体推荐。
局限性
- 原文结论指出支持潜在降级随访尚待前瞻性验证。
- 本研究为回顾性队列研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
BACKGROUND AND PURPOSE: To evaluate if reducing contrast-enhanced computed tomography (CECT) frequency via unenhanced CT impacts survival in stage I-III colorectal cancer (CRC).
MATERIALS AND METHODS: We conducted a retrospective cohort study of consecutive patients with stage I-III CRC who underwent curative resection at Yunnan Cancer Hospital between January 2012 and January 2020. Patients were categorized into high-frequency (>50% of follow-up scans as CECT) and low-frequency (≤50%) groups. Propensity score matching (PSM) was performed in a 1:4 ratio using nearest-neighbor matching with a caliper of 0.05, incorporating variables such as age, sex, tumor stage, surgical approach, adjuvant chemotherapy, tumor location, and preoperative carcinoembryonic antigen (CEA) levels to balance baseline characteristics. Overall survival (OS) and disease-free survival (DFS) were assessed using Kaplan-Meier curves, log-rank tests, and multivariable Cox proportional hazards models, with subgroup analyses.
RESULTS: Of 2,180 eligible patients, 2,063 were in the high-frequency group and 117 in the low-frequency group. After PSM, 543 patients were matched (432 high-frequency, 111 low-frequency), achieving balance (all standardized mean differences <0.1). With a median follow-up of 78.78 months, OS events occurred in 19.27% of patients and DFS events in 21.1%. No significant differences in OS (hazard ratio [HR] 1.106, 95% CI 0.696-1.757, P = 0.671) or DFS (HR 0.978, 95% CI 0.666-1.438, P = 0.911) were observed between groups. Multivariable analysis confirmed CECT frequency was not associated with outcomes. Subgroup analyses showed no significant interactions.
CONCLUSION: Reducing CECT frequency does not appear to compromise OS or DFS in this cohort, supporting potential de-escalation in selected patients, pending prospective validation.
引用
- Zhang Y, Liu L, Shi Z, et al. Impact of contrast-enhanced computed tomography surveillance frequency on survival outcomes in patients with stage I-III colorectal cancer: A propensity score-matched retrospective cohort study. Eur J Radiol. 2026. PMID: 41849866. doi:10.1016/j.ejrad.2026.112804
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。